Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Behçet's Disease

(2011) Kamel Hamzaoui et al.   JOURNAL OF NEUROIMMUNOLOGY

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

(2010) S. Sugita et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment

(2010) Y. Yamada et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

(2010) Nobuhisa Mizuki et al.   NATURE GENETICS

Genome-wide association study identifies variants in the MHC class I, IL10 and IL23R-IL12RB2 regions associated with Behçet's disease

(2010) Elaine F Remmers et al.   NATURE GENETICS

IL-17 and Th17 Cells

(2009) Thomas Korn et al.   Annual Review of Immunology

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behcet disease

(2009) Y. Yamada et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Suppression of Experimental Autoimmune Uveoretinitis by Anti-IL-17 Antibody

(2009) Rui Zhang et al.   CURRENT EYE RESEARCH

Major Role of    T Cells in the Generation of IL-17+ Uveitogenic T Cells

(2009) Y. Cui et al.   JOURNAL OF IMMUNOLOGY

FOXP3 and the regulation of Treg/Th17 differentiation

(2009) Steven F. Ziegler et al.   MICROBES AND INFECTION

Infliximab Effects Compared to Conventional Therapy in the Management of Retinal Vasculitis in Behçet Disease

(2008) Khalid F. Tabbara et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY